42 results
8-K
EX-99.1
GRTX
Galera Therapeutics Inc
14 Aug 23
Galera Reports Second Quarter 2023 Financial Results and Recent Corporate Updates
7:10am
funding or enter into any desired strategic alternative or partnership, it may need to cease operations; the impact of the COVID-19 pandemic on Galera’s
8-K
EX-99.1
GRTX
Galera Therapeutics Inc
10 Aug 23
Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese
8:00am
or healthcare reform initiatives; environmental, health and safety laws and regulations; the impact of the COVID-19 pandemic on Galera’s business
8-K
EX-99.1
t9yb1sh
11 May 23
Galera Reports First Quarter 2023 Financial Results and Recent Corporate
7:11am
8-K
EX-99.1
7ybir1f34tc
12 Dec 22
Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis
8:00am
8-K
EX-99.1
ogi8x6ixj
9 Nov 22
Galera Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
7:06am
8-K
EX-99.1
h3m3auzc
26 Oct 22
Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
1:41pm
8-K
EX-99.1
dz0 zr101
9 Aug 22
Galera Reports Second Quarter 2022 Financial Results and Recent Corporate Updates
7:00am
8-K
EX-99.1
55zuo4pfhwa
16 May 22
Galera Reports First Quarter 2022 Financial Results and Recent Corporate Updates
7:36am
8-K
EX-99.1
2wckr7dlrg f5y98f4px
10 Mar 22
Galera Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Updates
7:05am
8-K
EX-99.1
a0yjh ddi8ubfsr8
14 Dec 21
Galera Announces Primary Endpoint Met Statistical Significance in Corrected
7:06am
8-K
18azyr441v1h1l17sg2
14 Dec 21
Galera Announces Primary Endpoint Met Statistical Significance in Corrected
7:06am